Case Report
Accepted on 15 Jul 2025
Intradural Paragangliomas in the cauda equina region: A case report and literature review
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1642760
Type at least 3 characters
1,408 articles
Original Research
Accepted on 15 Jul 2025
Characteristics and Prognostic Analysis of Cystic Vestibular Schwannomas: Prolonged Surgical Duration with Limited Impact on Neurological Function
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1589941
Case Report
Accepted on 14 Jul 2025
Extensive Locally Invasive Nasopharyngeal Carcinoma Involving 10 Cranial Nerves Palsies: An Interesting Case Report
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1545838
Original Research
Published on 11 Jul 2025
Candidate gene mutations of patients with astrocytoma who present with seizures: evidence from whole exome sequencing
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1577344
- 406 views
Original Research
Accepted on 09 Jul 2025
Evaluating Treatment Strategies and Machine Learning Based Treatment Recommendation System for Elderly Patients with High Grade Gliomas
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1597925
- 269 views
Case Report
Accepted on 09 Jul 2025
Postoperative Microcystic Meningioma of the Fourth Ventricle with Subsequent Giant Cell Reparative Granuloma: A Case Report
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1624498
Original Research
Published on 09 Jul 2025
Relationship between DTI-MRI derived metrics and radiotherapy dose range in the contralateral cerebrum in lower grade glioma
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1406340
- 480 views
Case Report
Published on 08 Jul 2025
Case Report: Improved hearing in a rare, adult IDH2-mutant brainstem astrocytoma successfully treated with radiation and temozolomide
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1555986
- 594 views
Original Research
Accepted on 30 Jun 2025
Integrative Analysis of Polyamine Metabolism-Related Genes in Gliomas: Implications for Prognosis and Therapy
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1517557
- 129 views
Original Research
Accepted on 27 Jun 2025
The Protease-activated receptors (PARs) are expressed in glioblastoma and differentially modulate adherent versus stem-like growth of LN-18 GBM cells
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1582996
- 156 views
Original Research
Published on 27 Jun 2025
Dosimetric evaluation of a novel automated noncoplanar volumetric modulated arc therapy technique for treating optic nerve sheath meningiomas
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1531918
- 550 views
Mini Review
Published on 27 Jun 2025
Vorasidenib for IDH-mutant grade 2 gliomas: clinical advances and future directions
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1628195
- 694 views
Original Research
Published on 26 Jun 2025
CRP/albumin ratio and WBC values correlate with Ki-67 and survival in glioblastoma multiforme
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1612212
- 540 views
Original Research
Published on 25 Jun 2025
Integrative analysis of crotonylation-associated genes reveals prognostic and therapeutic targets in gliomas
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1573997
- 715 views
Original Research
Published on 20 Jun 2025
Multi-omics profiling of TGF-β isoforms and regulatory miRNAs in astrocytic tumors reveals TGF-β-3 as a prognostic biomarker
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1592685
- 765 views
Original Research
Published on 18 Jun 2025
Human annexin A5 promotes glioma progression by targeting the MAPK/CD44 pathway
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1550961
- 801 views